Clinical Trials
7 trialsNCT03781986 2026-03-03
APG-115 in Salivary Gland Cancer Trial
University of Michigan Rogel Cancer Center
Phase 1/2 Active not recruiting
NCT06118086 2026-02-18
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
Remix Therapeutics
Phase 1/2 Recruiting
NCT03556228 2025-12-11
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
VM Oncology, LLC
Phase 1/2 Recruiting
NCT05774899 2025-06-17
CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC
Dana-Farber Cancer Institute
Phase 1/2 Recruiting
NCT04140526 2025-05-23
PRESERVE-001
OncoC4, Inc.
Phase 1/2 Active not recruiting
NCT03422679 2024-01-16
Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies
Cellestia Biotech AG
Phase 1/2 Terminated
NCT01192087 2013-04-24
ACCEPT
Heidelberg University
Phase 1/2 Unknown